Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574

A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353

Coronavirus as a possible cause of severe acute respiratory syndrome

Peiris, M. J. S., Lai, S., Poon, L. L. M., Guan, Y., Yam, L., Lim, W., Nicholls, J. M., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,916

Infectious Diseases

Blacklow, N. R., Gorbach, S. L., & Bartlett, J. G. (1992) · Cited by 2,753

Bats Are Natural Reservoirs of SARS-Like Coronaviruses

Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571

Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R. P., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,477

Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China

Guan, Y., Zheng, B., He, Y., Liu, X. L., Zhuang, Z. X., Cheung, C. L., Luo, S., Li, P. H., Zhang, L., Guan, Y., et al. (2003) · Science · doi:10.1126/science.1087139 · Cited by 2,404

Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor

Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,035

The Genome Sequence of the SARS-Associated Coronavirus

Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A. R., Butterfield, Y. S. N., Khattra, J. S., Asano, J. K., Barber, S., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,027

Development of a Unique Rapid Test to Detect Anti-bodies Directed Against an Extended RBD of SARS-CoV-2 Spike Protein

Brosi, L., Villiger, T. K., Bantleon, F. I., Melone, A., Überschlag, M.-E., Dolce, D., Giegelmann, C., Gerspach, M. A., Dirscherl, L., Panikulam, S., et al. (2021) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2021.446 · Cited by 2

SARS Coronavirus Pathogenesis and Therapeutic Treatment Design

Sheahan, T. P., & Baric, R. S. (2009) · Springer eBooks · doi:10.1007/978-3-642-03683-5_13 · Cited by 4

Vaccines for Severe Acute Respiratory Syndrome Virus and Other Coronaviruses

Enjuanes, L., DeDiego, M. L., Álvarez, E. A., Capiscol, C., & Baric, R. S. (2014) · ASM Press eBooks · doi:10.1128/9781555815790.ch25 · Cited by 3

Immunoinformatics lessons on the current COVID-19 pandemic and future coronavirus zoonoses

López, D., & García-Peydró, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1118267 · Cited by 2

Computational characterization and design of SARS coronavirus receptor recognition and antibody neutralization

Zhang, Y., Zheng, N., & Zhong, Y. (2007) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2007.02.005 · Cited by 2

Aspect of COVID-19 Pandemic: Case for Mass Spectrometry

Albarbarawi, O. (2023) · Medicinal & Analytical Chemistry International · doi:10.23880/macij-16000177 · Cited by 1

Reactivity and Safety of BioNTech/Pfizer® Vaccine Anti-SARS-CoV-2, in Health Personnel from the Mexican State of Guanajuato

Navarro-Olivos, E., Magos-Vázquez, F. J., Sánchez-Navarro, M. D. R., Díaz-Martínez, D. A., Gallardo-Luna, M. D. J., & Raygoza, N. P. (2022) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2435 · Cited by 1

Stress adaptation signature into the functional units of spike, envelope, membrane protein and ssRNA of SARS-CoV-2.

Sarkar, A., & Panja, A. S. (2022) · PubMed Central · doi:10.22099/mbrc.2022.44594.1777 · Cited by 1

mRNA Based Vaccine Studies in Infectious Diseases and Current Developments

Savaşçı, Ü., & Gül, H. C. (2021) · Journal of Molecular Virology and Immunology · doi:10.46683/jmvi.2020.19 · Cited by 1

Could SARS-CoV-1 Vaccines in the Pipeline Have Contributed to Fighting the COVID-19 Pandemic? Lessons for the Next Coronavirus Plague

López, D., & García-Peydró, M. (2023) · Biomedicines · doi:10.3390/biomedicines12010062 · Cited by 1

A Polypeptide of Tumor-Associated Antigen L6 with Intrinsic Adjuvant Activity Enhances Antitumor Immunity

Sher, Y., Chai, K. M., Chen, W., Shen, K., Chen, I.-H., Lee, M.-H., Chiu, F., & Liu, S. (2020) · Vaccines · doi:10.3390/vaccines8040620 · Cited by 1

CORONAVIRUS VACCINE DEVELOPMENT: FROM SARS AND MERS TO COVID-19 (RUSSIAN TRANSLATION)

Li, Y.-D., Chi, W.-Y., Su, J.-H., Ferrall, L., Hung, C., & Wu, T. ‐. (2020) · Juvenis scientia · doi:10.32415/jscientia_2020_6_6_41-80 · Cited by 1

Vaccine Development and Immune Responses in COVID-19: Lessons from the Past

Fatemi, F., Nejad, Z. H., & Siadat, S. E. R. (2021) · Springer eBooks · doi:10.1007/978-981-16-3108-5_5 · Cited by 1

Structure-Based Design of Recombinant Spike Subunit Vaccine for Coronavirus Diseases

Mahmuda, M., Jannah, S. A., Fibriani, A., Ningrum, R. A., & Wardiana, A. (2023) · International Journal on Advanced Science Engineering and Information Technology · doi:10.18517/ijaseit.13.1.16202 · Cited by 1

In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effectPreprint

Boubaker, S., Othman, H., Touati, R., Ayouni, K., Lakhal, M., Ben‐Mustapha, I., Ghedira, K., Kharrat, M., & Triki, H. (2021) · Research Square · doi:10.21203/rs.3.rs-105598/v3 · Cited by 1

In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of possible putative protective effectPreprint

Boubaker, S., Othman, H., Touati, R., Ayouni, K., Lakhal, M., Ben‐Mustapha, I., Ghedira, K., Kharrat, M., & Triki, H. (2020) · Research Square · doi:10.21203/rs.3.rs-105598/v2 · Cited by 1

The heptide repeat 2 and upstream region of TGEV induces potent cross-neutralizing antibodies against group I coronaviruses.

Shi, H., Wu, N., Wang, X., & Wang, T. (2012) · PubMed

Development of SARS-COV therapeutics using quaternary protein mimetics

Neo, T. L. (2009) · doi:10.32657/10356/41875

Molecular studies of coronavirus replication and pathogenesis

Li, Q. (2007) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/6584

The Devil in its Details: Unravelling the Epitopes in COVID-19 Surface Glycoprotein with the potential for Vaccination and Antibody SynthesisPreprint

Baig, A. M. (2020) · doi:10.21203/rs.3.rs-19497/v1

mRNA Based SARS-CoV-2 Vaccines and Ongoing Researches

Hoşbul, T., Yılmaz, Ü. İ., Aydoğan, C. N., & Şahiner, F. (2021) · Journal of Molecular Virology and Immunology · doi:10.46683/jmvi.2020.20

Is the New Global Threat Biological Warfare or Sustainable Health Security

Şahiner, F. (2021) · Journal of Molecular Virology and Immunology · doi:10.46683/jmvi.2021.27

Toward Optimization of the Baculovirus Expression Vector System - Development of Genetic Tools to Improve Biologics Production

Bruder, M. R. (2021) · UWSpace (University of Waterloo)

Bedeutung von Wirtszellproteasen für die Infektion mit dem Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV)

Glowacka, I. (2011) · Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) · doi:10.15488/7627

In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of possible putative protective effectPreprint

Boubaker, S., Othman, H., Touati, R., Ayouni, K., Lakhal, M., Ben‐Mustapha, I., Ghedira, K., Kharrat, M., & Triki, H. (2020) · Research Square · doi:10.21203/rs.3.rs-105598/v1

The Coronavirus Family, Its existence in mammals for centuries and The FuturePreprint

O’Carroll, A. (2020) · doi:10.31219/osf.io/f2eka

Strain Variation Based on Spike Glycoprotein Gene of SARS-CoV-2 in Kuwait from 2020 to 2021

Madi, N., Sadeq, M., Essa, S. S., Safar, H. A., Al‐Adwani, A., & Al-Khabbaz, M. (2022) · Pathogens · doi:10.3390/pathogens11090985

Test

Injeti, N. (2022) · International Journal of Experimental and Biomedical Research · doi:10.26452/ijebr.v1i3.382

Bioinformatic Tools for Studying the Cellular Immune Response to SARS-CoV-2, Vaccine Efficacy, and Future Pandemics at the Global Population Level

López, D., & Zumárraga, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413477

Additional file 3 of In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect

Haddad-Boubaker, S., Othman, H., Touati, R., Ayouni, K., Lakhal, M., Ben‐Mustapha, I., Ghedira, K., Kharrat, M., & Triki, H. (2021) · Figshare · doi:10.6084/m9.figshare.14329687

Additional file 1 of In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect

Haddad-Boubaker, S., Othman, H., Touati, R., Ayouni, K., Lakhal, M., Ben‐Mustapha, I., Ghedira, K., Kharrat, M., & Triki, H. (2021) · Figshare · doi:10.6084/m9.figshare.14329681

Additional file 4 of In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect

Haddad-Boubaker, S., Othman, H., Touati, R., Ayouni, K., Lakhal, M., Ben‐Mustapha, I., Ghedira, K., Kharrat, M., & Triki, H. (2021) · Figshare · doi:10.6084/m9.figshare.14329690

Additional file 2 of In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect

Haddad-Boubaker, S., Othman, H., Touati, R., Ayouni, K., Lakhal, M., Ben‐Mustapha, I., Ghedira, K., Kharrat, M., & Triki, H. (2021) · Figshare · doi:10.6084/m9.figshare.14329684

Autologous hinge-masked anti-TNFα antibody to mitigate immunogenicity, antigen sink effects, and anti-idiotypic antibody interference

Huang, B., Lu, Y.-C., Chuang, C., Hong, S.-T., Ho, K., Cheng, Y., Liao, T.-Y., Liu, E.-S., Liao, J., Chen, C.-Y., et al. (2026) · Journal of Biological Engineering · doi:10.1186/s13036-026-00741-x

Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: Revealing the critical antigenic determinants in inactivated SARS-CoV vaccine

He, Y., Li, J., Du, L., Yan, X., Hu, G., Zhou, Y., & Jiang, S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.054 · Cited by 62

Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines

He, Y., Zhu, Q., Liu, S., Zhou, Y., Baoan, Y., Li, J., & Jiang, S. (2005) · Virology · doi:10.1016/j.virol.2005.01.034 · Cited by 100

Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies

He, Y., Lü, H., Siddiqui, P., Zhou, Y., & Jiang, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4908 · Cited by 238

A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice

Zhou, Z., Post, P. L., Chubet, R. G., Holtz, K., McPherson, C. E., Petrić, M., & Cox, M. M. J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.01.059 · Cited by 89

Recombinant Modified Vaccinia Virus Ankara Expressing the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus Induces Protective Neutralizing Antibodies Primarily Targeting the Receptor Binding Region

Chen, Z., Zhang, L., Qin, C., Ba, L., Yi, C. E., Zhang, F., Wei, Q., Tian, H., Yu, W., Yu, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2678-2688.2005 · Cited by 181